combination therapy with glp-1 receptor agonist and sglt2 inhibitor Efficacy safety of the or monotherapy agonists and SGLT-2 inhibitors in Type 2 diabetes mellitus: An update systematic review and meta-analysis GLP-1 Therapeutics and Their Brain & Sleep Type:Paperback

combination therapy with glp-1 receptor agonist and sglt2 inhibitor Efficacy safety of the or monotherapy agonists and SGLT-2 inhibitors in Type 2 diabetes mellitus: An update systematic review and meta-analysis GLP-1 Therapeutics and Their Brain & Sleep Type:Paperback

GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer - PMC

doi: 10.3803/EnM.2021.102 Summary Keywords GLP-1 receptor agonists, endocrine, cardiovascular, neurological, cancer Citation Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y and Zhang Y (2021) GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects

Brain & Sleep

Type:Paperback

As a GLP-1 receptor agonist, it mimics the body's own hormone GLP-1 (glucagon-like peptide-1) and selectively binds to the GLP-1 receptor, thereby stimulating the secretion of insulin and lowering blood glucose levels [15]